Take the online posttest.


VOLUME 67   2006   SUPPLEMENT 13

Psychiatry in Brief:
Insomnia and Emerging Therapies:
Treating the Whole Patient

CME Background Information
[PDF]

ARTICLES

3 Overview: Importance of Recognizing and Treating Insomnia. William M. Glazer
[PDF]

5 Trends in the Pharmacologic Management of Insomnia. Paul P. Doghramji
[Abstract] [PDF]

9 Influence of Pharmacokinetic Profiles on Safety and Efficacy of Hypnotic Medications. Milton K. Erman
[Abstract] [PDF]

13 Questions and Answers: The Role of Pharmacotherapy in the Clinical Management of Insomnia.
[PDF]

CME Section

17 Instructions and Posttest.
[PDF]

19 Registration Form and Evaluation.
[PDF]

Editor’s Choice

Sleep—or the lack thereof—continues to be a major problem for our patients, with the potential not only for decreasing function and quality of life, but for worsening other medical and psychiatric illness. In this PSYCHIATRY IN BRIEF offering, William M. Glazer, M.D., describes the impact of insomnia on functioning and on comorbid conditions. Next, Paul P. Doghramji, M.D., gives an overview of current and emerging treatments for insomnia and the way people and their clinicians have treated this problem. Milton K. Erman, M.D., closes with an excellent review of the safety and efficacy of available agents, with an emphasis on the newer agents and the critical importance of matching half-life with symptom pattern.These articles are followed by a Questions and Answers section providing practical case-based insights responsive to the priority questions many of us in primary care have about the treatment options currently available. This PSYCHIATRY IN BRIEF will prepare primary care physicians for practical decisions they face in the office.

Larry Culpepper, MD, MPH

Editor in Chief

The Primary Care Companion to the Journal of Clinical Psychiatry